Search
for
Sort by
Research 661–690 of 1000+
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
- A Case of Gynecomastia Induced by Use of Doxazosin
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Prace poglądowe Folate supplementation in patients with psoriasis treated with methotrexate – effect on safety and efficacy
- Evaluation of the activity of laser light doses compared to an inactive control dose on ex vivo hair growth
- Hair care practices in different populations: What makes a difference?
- Androgen treatment in women
- Hair disorders update: Alopecia to hirsutism
- Westwood Carolina Conference on Clinical Dermatology
- Interventions for female pattern hair loss
- Mujer con caída de cabello en el posparto
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Harmless Herbs? A Review of the Recent Literature
- Is dehydroepiandrosterone a hormone?
- Treatment of invasive aspergillosis with itraconazole
- The Rotterdam Study: 2016 objectives and design update
- Severe cutaneous adverse reactions to drugs
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Telogen Effluvium
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Evaluation and treatment of male and female pattern hair loss
- The PDGF/PDGFR pathway as a drug target
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
- Androgenetic alopecia: pathogenesis and potential for therapy
- Cutaneous complications of chemotherapeutic agents
- Endocrinology of Transgender Medicine